Clinical Trials Resource Center

Therapeutic Areas: Dermatology | Immunology | Musculoskeletal | Rheumatology

Cutaneous Lupus Erythematosus Clinical Trials

A listing of Cutaneous Lupus Erythematosus medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Research Center
Anniston Alabama 36207

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

Anniston Alabama 36207

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Arizona

Phoenix Arizona 85032

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

California

Research Center
La Mesa California 91942

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

Research Center
Los Angeles California 90045

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

Research Center
Tustin California 92780

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

Research Center
Upland California 91786

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

Research Center
Upland California 91786

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

Research Center
West Hills California 91307

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

UPDATED

Beverly Hills California 90211

A clinical trial to evaluate treatments using Filgotinib, GS-9876, Filgotinib placebo and GS-9876 placebo for patients with Cutaneous Lupus Erythematosus

UPDATED

Los Angeles California 90045

A clinical trial to evaluate treatments using Filgotinib, GS-9876, Filgotinib placebo and GS-9876 placebo for patients with Cutaneous Lupus Erythematosus

Los Angeles California 90045

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

UPDATED

Palm Desert California 92260

A clinical trial to evaluate treatments using Filgotinib, GS-9876, Filgotinib placebo and GS-9876 placebo for patients with Cutaneous Lupus Erythematosus

UPDATED

San Diego California 92103

A clinical trial to evaluate treatments using Filgotinib, GS-9876, Filgotinib placebo and GS-9876 placebo for patients with Cutaneous Lupus Erythematosus

San Diego California 92120

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

UPDATED

Tustin California 92780

A clinical trial to evaluate treatments using Filgotinib, GS-9876, Filgotinib placebo and GS-9876 placebo for patients with Cutaneous Lupus Erythematosus

Tustin California 92780

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Upland California 91786

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

West Hills California 91307

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

West Hollywood California 90048

Patients are needed to participate in a clinical research study of Milatuzumab

Colorado

UPDATED

Denver Colorado 80230

A clinical trial to evaluate treatments using Filgotinib, GS-9876, Filgotinib placebo and GS-9876 placebo for patients with Cutaneous Lupus Erythematosus

Florida

UPDATED

Clearwater Florida 33765

A clinical trial to evaluate treatments using Filgotinib, GS-9876, Filgotinib placebo and GS-9876 placebo for patients with Cutaneous Lupus Erythematosus

UPDATED

DeBary Florida 32713

A clinical trial to evaluate treatments using Filgotinib, GS-9876, Filgotinib placebo and GS-9876 placebo for patients with Cutaneous Lupus Erythematosus

Orlando Florida 32806

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Georgia

Research Center
Sandy Springs Georgia 30328

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

Atlanta Georgia 30342

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Illinois

UPDATED

Chicago Illinois 60611

A clinical trial to evaluate treatments using Filgotinib, GS-9876, Filgotinib placebo and GS-9876 placebo for patients with Cutaneous Lupus Erythematosus

Indiana

Research Center
Indianapolis Indiana 46256

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

Indianapolis Indiana 46256

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Massachusetts

Research Center
Boston Massachusetts 02115

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

Boston Massachusetts 02115

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Michigan

Research Center
Ann Arbor Michigan 48109

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

Ann Arbor Michigan 48109

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Missouri

Research Center
St. Louis Missouri 63110

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

St. Louis Missouri 63110

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Nevada

Research Center
Las Vegas Nevada 89128

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

Las Vegas Nevada 89128

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

New Jersey

Summit New Jersey 07901

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

New York

Research Center
Great Neck New York 11021

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

Great Neck New York 11020

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

North Carolina

Research Center
Chapel Hill North Carolina 27599

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

Research Center
Charlotte North Carolina 28207

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

Research Center
Charlotte North Carolina 28204

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

Research Center
Greensboro North Carolina 27408

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

Research Center
Wilmington North Carolina 28401

LILAC Study – For Patients with Cutaneous and/or Systemic Lupus

UPDATED

Charlotte North Carolina 28210

A clinical trial to evaluate treatments using Filgotinib, GS-9876, Filgotinib placebo and GS-9876 placebo for patients with Cutaneous Lupus Erythematosus

Charlotte North Carolina 28207

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Charlotte North Carolina 28204

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Greensboro North Carolina 27408

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)